Atkinson Edward Morrow III 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 28, 2025
Insider Transaction Report
Form 4
Atkinson Edward Morrow III
EVP, Chief Technical Ops. Off.
Transactions
- Sale
Common Stock
2025-02-27$475.34/sh−2,650$1,259,651→ 19,352 total - Tax Payment
Common Stock
2025-02-26$479.61/sh−2,482$1,190,392→ 22,002 total
Footnotes (1)
- [F1]Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024.